As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...
DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an ...
DelveInsight's "TAGRISSO Market Size, Forecast, and Market Insight Report" highlights the details around TAGRISSO, a kinase ...
Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, ...
WeDriveU Customers Named Best Workplaces and Best Universities for Commuters in 2025 WeDriveU logo Annual award program honors emplo ...
When Shevonya Noble joined biotechnology firm Genentech as a principal quality and compliance leader, she was connected with ...
DelveInsight's Interferons Market Insights report provides the current and forecast market analysis, individual leading ...
Genentech, a member of Roche (RHHBY), announced that the FDA has accepted the company’s supplemental biologics license application for Gazyva ...
BARCELONA, Spain, March 5, 2025 /PRNewswire/ -- GTS Techlabs, the technology arm of Globe Teleservices (GTS), a leading telecom solution company, and Peacom have announced a strategic partnership at ...
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
13d
Just nine weeks after UnitedHealthcare CEO Brian Thompson was murdered on a weekday morning on a busy street, the luminaries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback